Sidoti Micro-Cap Virtual Conference
Logotype for Acme United Corporation

Acme United (ACU) Sidoti Micro-Cap Virtual Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Acme United Corporation

Sidoti Micro-Cap Virtual Conference summary

20 May, 2026

Business overview and segment performance

  • Operates in two main segments: cutting solutions (Westcott brand, global leader, 70 million scissors/year) and first aid/safety (larger, high recurring revenue from refills, 8%-10% organic growth).

  • Cutting segment is mature, slow-growing, but generates strong cash flow and holds leading market shares across diverse applications.

  • First aid and safety segment benefits from regulatory drivers, high margins, and a broadening product portfolio, including bleed control and arrhythmia solutions.

  • Recent emphasis on expanding first aid/safety due to its broader market, life-saving impact, and annuity-like revenue stream.

  • Acquisitions in first aid focus on vertical integration and expanding product offerings, such as the My Medic acquisition.

Growth strategy and recent initiatives

  • Organic growth historically 6%-7%, with first aid outpacing cutting; tariffs impacted retail last year, but first aid remained strong.

  • My Medic acquisition adds $19 million in sales, strong D2C presence, and 500,000 social media followers, enhancing direct consumer engagement and training.

  • Integration of My Medic focuses on leveraging existing distribution, expanding Amazon presence, and achieving cost efficiencies through sourcing and vertical integration.

  • Cutting segment expects growth in Q2 and Q3, driven by new customers (e.g., dollar stores), expanded craft product lines, and increased retail promotions.

  • International expansion is a priority for first aid, with significant growth in Europe and Canada, and a new facility opening near Montreal.

Financials, margins, and capital allocation

  • EBITDA ranges from $20M-$25M, funding acquisitions, dividends (~$2M/year), and facility investments.

  • CapEx is $6M-$7M annually, with $1M for maintenance and the rest for automation and productivity improvements across nine North American plants.

  • Gross margins run 39%-40%, with first aid slightly higher than cutting; My Medic has higher gross margins but also higher SG&A due to D2C marketing.

  • About 20% of revenue is international, with ongoing efforts to increase this share.

  • Targeting $225M-$230M in revenue this year, aiming for $300M within three years through 8%-10% annual growth and further acquisitions in first aid.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more